Filana Therapeutics Inc. Common Stock (FLNA)
Stock · NASDAQ · Health Care
$0.702as of 10/16/2026
Price chart
Active signals
FLNA Signal Track Record
How signals performed across all stocks →What FLNA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -2.8% | 34% | September 22, 2026 |
| Bollinger Band Breakout | 19 | -8.2% | 37% | September 22, 2026 |
| Bollinger Band Breakdown | 18 | +1.4% | 50% | September 3, 2026 |
| 200-Day Moving Average TouchActive now | 10 | +1.3% | 50% | May 29, 2024 |
| Any 20-session window (baseline) | -3.9% | 39% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About FLNA
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of bl…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 17
- Website
- www.cassavasciences.com/
Fundamentals
- 1-day range
- $0.702$0.7689
- Market cap
- $46.33M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.88
- Dividend yield
- —
- Beta
- 1.46
- Avg. volume
- 2.03M
- Ex-dividend date
- December 13, 2012
Forecasts
2 analyst ratings
Filana Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- FLNAFilana Therapeutics Inc. Common Stock$0.7▼ 7.89%Market cap $46.33MP/E —$0.6701$2.27
- CNTXContext Therapeutics Inc. Common Stock$0.244▲ 1.24%Market cap $46.31MP/E —$0.2358$3.62
- MREOMereo BioPharma Group plc American Depositary Shares$0.303▼ 1.94%Market cap $47.46MP/E —$0.2$2.37
- EDSAEdesa Biotech Inc. Common Shares$2.57▼ 3.75%Market cap $44.90MP/E —$0.72$20.32
- MCRBSeres Therapeutics Inc. Common Stock$2.46▼ 2.77%Market cap $48.42MP/E —$2.8$29.98
- KPTIKaryopharm Therapeutics Inc. Common Stock$0.39▲ 11.11%Market cap $44.19MP/E —$0.31$10.99
- TCRTAlaunos Therapeutics Inc. Common Stock$2.63▲ 20.64%Market cap $48.60MP/E —$0.719$4.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FLNA Filana Therapeutics Inc. Common Stock | $46.33M | — | $0.7 | ▼ 7.89% | $0.6701$2.27 |
| CNTX Context Therapeutics Inc. Common Stock | $46.31M | — | $0.244 | ▲ 1.24% | $0.2358$3.62 |
| MREO Mereo BioPharma Group plc American Depositary Shares | $47.46M | — | $0.303 | ▼ 1.94% | $0.2$2.37 |
| EDSA Edesa Biotech Inc. Common Shares | $44.90M | — | $2.57 | ▼ 3.75% | $0.72$20.32 |
| MCRB Seres Therapeutics Inc. Common Stock | $48.42M | — | $2.46 | ▼ 2.77% | $2.8$29.98 |
| KPTI Karyopharm Therapeutics Inc. Common Stock | $44.19M | — | $0.39 | ▲ 11.11% | $0.31$10.99 |
| TCRT Alaunos Therapeutics Inc. Common Stock | $48.60M | — | $2.63 | ▲ 20.64% | $0.719$4.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Filana Therapeutics to Participate in the 2026 Maxim Growth SummitYahoo · 10/9/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 10/1/2026
- These stocks are moving in today's after hours sessionChartMill · 9/30/2026
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 9/30/2026
- Unusual volume stocks in Wednesday's sessionChartMill · 9/23/2026
- Gapping stocks in Wednesday's sessionChartMill · 9/23/2026
- These stocks are moving in today's after hours sessionChartMill · 9/22/2026
- Which stocks are experiencing notable movement on Tuesday?ChartMill · 9/22/2026
Insider Activity
Insider Actions →- Richard Barry · September 30, 2026 · Buy100.0K @ $0.92
- Richard Barry · September 29, 2026 · Buy206.8K @ $0.9
Institutional Ownership
March 31, 2026
- Total shares held
- 14.11M
- Total value held
- $22.94M
- Institutional holders
- 97
- Unknown2.01M
- Unknown1.99M
- Unknown1.93M
- Unknown1.41M
- Unknown749.2K
- Unknown596.2K
- Unknown559.2K
- Unknown450.1K
- Unknown328.6K
- Unknown326.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
FLNA sees unusual volume and after-hours movement
Filana Therapeutics (FLNA) appeared on multiple lists for unusual trading volume and price gaps during recent sessions. The stock also showed notable movement in after-hours trading, drawing attention from market scanners. These technical signals suggest increased investor interest or reaction to recent developments, though no specific corporate news was provided in the data.
FLNA sees unusual volume and after-hours movement. Filana Therapeutics (FLNA) appeared on multiple lists for unusual trading volume and price gaps during recent sessions. The stock also showed notable movement in after-hours trading, drawing attention from market scanners. These technical signals suggest increased investor interest or reaction to recent developments, though no specific corporate news was provided in the data.